JP6104390B2 - ミクロスフェアを含む改良された創傷治癒用組成物 - Google Patents

ミクロスフェアを含む改良された創傷治癒用組成物 Download PDF

Info

Publication number
JP6104390B2
JP6104390B2 JP2015531687A JP2015531687A JP6104390B2 JP 6104390 B2 JP6104390 B2 JP 6104390B2 JP 2015531687 A JP2015531687 A JP 2015531687A JP 2015531687 A JP2015531687 A JP 2015531687A JP 6104390 B2 JP6104390 B2 JP 6104390B2
Authority
JP
Japan
Prior art keywords
wound
microspheres
specific gravity
polystyrene
wounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2015531687A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015528492A5 (cg-RX-API-DMAC7.html
JP2015528492A (ja
Inventor
リッター，ブラディマー
クレイマン，メリー
ハナ バートフェルド，デボラ
ハナ バートフェルド，デボラ
アスクライ，エイロン
Original Assignee
ポリヒール リミテッド
ポリヒール リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ポリヒール リミテッド, ポリヒール リミテッド filed Critical ポリヒール リミテッド
Publication of JP2015528492A publication Critical patent/JP2015528492A/ja
Publication of JP2015528492A5 publication Critical patent/JP2015528492A5/ja
Application granted granted Critical
Publication of JP6104390B2 publication Critical patent/JP6104390B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/745—Polymers of hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0014—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2015531687A 2012-09-13 2013-09-12 ミクロスフェアを含む改良された創傷治癒用組成物 Active JP6104390B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261700362P 2012-09-13 2012-09-13
US61/700,362 2012-09-13
PCT/IL2013/050774 WO2014041543A1 (en) 2012-09-13 2013-09-12 Improved wound healing compositions comprising microspheres

Publications (3)

Publication Number Publication Date
JP2015528492A JP2015528492A (ja) 2015-09-28
JP2015528492A5 JP2015528492A5 (cg-RX-API-DMAC7.html) 2016-09-29
JP6104390B2 true JP6104390B2 (ja) 2017-03-29

Family

ID=50277729

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015531687A Active JP6104390B2 (ja) 2012-09-13 2013-09-12 ミクロスフェアを含む改良された創傷治癒用組成物

Country Status (17)

Country Link
US (1) US9370533B2 (cg-RX-API-DMAC7.html)
EP (1) EP2895209B1 (cg-RX-API-DMAC7.html)
JP (1) JP6104390B2 (cg-RX-API-DMAC7.html)
KR (1) KR102200656B1 (cg-RX-API-DMAC7.html)
AU (1) AU2013316718B2 (cg-RX-API-DMAC7.html)
BR (1) BR112015005335B1 (cg-RX-API-DMAC7.html)
CA (1) CA2883455C (cg-RX-API-DMAC7.html)
DK (1) DK2895209T3 (cg-RX-API-DMAC7.html)
ES (1) ES2748805T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20191804T1 (cg-RX-API-DMAC7.html)
HU (1) HUE047212T2 (cg-RX-API-DMAC7.html)
LT (1) LT2895209T (cg-RX-API-DMAC7.html)
MX (1) MX359713B (cg-RX-API-DMAC7.html)
PL (1) PL2895209T3 (cg-RX-API-DMAC7.html)
PT (1) PT2895209T (cg-RX-API-DMAC7.html)
RS (1) RS59410B1 (cg-RX-API-DMAC7.html)
WO (1) WO2014041543A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107205624B (zh) * 2014-10-29 2019-08-06 光谱Md公司 用于组织分类的反射式多光谱时间分辨光学成像方法和装备
CN110573066A (zh) 2017-03-02 2019-12-13 光谱Md公司 用于多光谱截肢部位分析的机器学习系统和技术
WO2020123724A1 (en) 2018-12-14 2020-06-18 Spectral Md, Inc. Machine learning systems and methods for assessment, healing prediction, and treatment of wounds
JP7186298B2 (ja) 2018-12-14 2022-12-08 スペクトラル エムディー，インコーポレイテッド 高精度マルチアパーチャスペクトルイメージングのためのシステムおよび方法
US10783632B2 (en) 2018-12-14 2020-09-22 Spectral Md, Inc. Machine learning systems and method for assessment, healing prediction, and treatment of wounds
US10740884B2 (en) 2018-12-14 2020-08-11 Spectral Md, Inc. System and method for high precision multi-aperture spectral imaging

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5614310A (en) * 1994-11-04 1997-03-25 Minnesota Mining And Manufacturing Company Low trauma wound dressing with improved moisture vapor permeability
US5861149A (en) * 1997-06-04 1999-01-19 Polyheal Ltd. Methods for wound treatment
IL136583A0 (en) 1998-10-23 2001-06-14 Polyheal Ltd Compositions of microspheres for wound healing
EP1368354A1 (en) * 2001-03-07 2003-12-10 Pfizer Products Inc. Modulators of chemokine receptor activity
US7465463B2 (en) * 2002-09-04 2008-12-16 Polyheal, Ltd. Compositions comprising microspheres with anti-inflammatory properties for healing of ocular tissues
JP2009525975A (ja) * 2006-01-31 2009-07-16 ヴァション，デイビッド 多細胞生物の組織の治癒を促進するための組成物及びその方法
GB0607774D0 (en) * 2006-04-20 2006-05-31 Renovo Group Plc Medicaments

Also Published As

Publication number Publication date
AU2013316718B2 (en) 2016-09-29
BR112015005335A8 (pt) 2018-01-30
RS59410B1 (sr) 2019-11-29
LT2895209T (lt) 2019-10-25
EP2895209A1 (en) 2015-07-22
ES2748805T3 (es) 2020-03-18
HRP20191804T1 (hr) 2019-12-27
PT2895209T (pt) 2019-10-28
EP2895209A4 (en) 2016-04-20
BR112015005335B1 (pt) 2020-03-10
DK2895209T3 (da) 2019-10-21
HK1212638A1 (en) 2016-06-17
US20150231170A1 (en) 2015-08-20
KR102200656B1 (ko) 2021-01-11
PL2895209T3 (pl) 2020-01-31
HUE047212T2 (hu) 2020-04-28
MX2015002816A (es) 2015-05-15
KR20150082207A (ko) 2015-07-15
MX359713B (es) 2018-10-08
US9370533B2 (en) 2016-06-21
CA2883455A1 (en) 2014-03-20
EP2895209B1 (en) 2019-07-17
WO2014041543A1 (en) 2014-03-20
JP2015528492A (ja) 2015-09-28
BR112015005335A2 (pt) 2017-07-04
CA2883455C (en) 2020-01-28
AU2013316718A1 (en) 2015-03-12

Similar Documents

Publication Publication Date Title
JP6104390B2 (ja) ミクロスフェアを含む改良された創傷治癒用組成物
CN114558110B (zh) 贻贝粘蛋白产品及其抑制皮肤炎症的应用
CN108135972B (zh) 贻贝粘蛋白产品治疗和预防黑色素相关疾病中的应用
AU2014212561A1 (en) Compositions and methods for treating surface wounds
US20080020025A1 (en) Composition for wound care and method of using same
KR20170018852A (ko) 상처 치료를 위한 국소 조성물 및 방법
BRPI0101486B1 (pt) Pharmaceutical composition for topic use containing heparin for the treatment of skin or mucosal injuries caused by burns
RU2433844C1 (ru) Способ лечения дегенеративно-дистрофических заболеваний опорно-двигательного аппарата и посттравматических болевых синдромов
US20230338296A1 (en) Devices and methods for delivery of oxygen to a wound
US10960011B2 (en) Compositions for the treatment of ischemic ulcers and stretch marks
JP6725108B2 (ja) ユニチオール及びジメチルスルホキシドを含む消毒組成物、その組成物の使用並びにそれを使用した創傷治療方法
EP3087990B1 (en) Gel-forming powder comprising sulfamonomethoxine and chitosan for treating wounds
RU2432942C1 (ru) Композиция для приготовления обладающей пролонгированным действием лекарственной формы для лечения орофарингеальной зоны
WO2007143586A2 (en) Composition for wound care and method of using same
HK1212638B (en) Improved wound healing compositions comprising microspheres
US20250312304A1 (en) Retinol acid pathway modulators for treatment of congenital vascular malformation
EA002267B1 (ru) Ранозаживляющий, противовоспалительный и противоинфекционный лекарственный препарат
Sar Development and characterisation of metformin loaded film with flaxseed gel for acceleration of healing process of burn wounds: an approach for tissue regeneration
EP2883541A1 (en) Composition for topical use comprising hyaluronic acid
CN101574363A (zh) 治疗烧伤的药物组合物
CN117617500A (zh) 一种适用于术后恢复的功能型配方粉及其制备方法和用法
El-Barbary et al. COMPARISON BETWEEN THE EFFECTIVENESS OF TOPICAL CANTHARIDIN-PODOPHYLLOTOXIN-SALICYLIC ACID VERSUS CRYOTHERAPY IN THE TREATMENT OF PLANTAR WARTS IN CHILDREN

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160810

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20160810

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20160810

A975 Report on accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A971005

Effective date: 20160908

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20160920

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20161212

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20170131

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20170228

R150 Certificate of patent or registration of utility model

Ref document number: 6104390

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250